Quantité totale PI	19
Rang # Quantité totale PI	78 563
Note d'activité PI	2,1/5.0    18
Rang # Activité PI	46 522
Classe Nice dominante	Services scientifiques, technolo...

Brevets Marques 4 2 6 0 7 0 0
Dernier brevet	2024 - Yap/taz-tead oncoproteins inhibi...
Premier brevet	2020 - Fgfr inhibitors for the treatmen...
Dernière marque	2023 - BG BRIDGENE BIOSCIENCES
Première marque	2019 - IMTAC

Industrie (Classification de Nice)

Derniers inventions, produits et services 2023 Invention Yap/taz-tead oncoproteins inhibitors. Provided are YAP/TAZ-TEAD oncoproteins inhibitors of Formul... P/S Pharmacological research utilizing biological technology based on structure-based probe design, c... Invention Imidazopyridine inhibitors of tyrosine kinase Invention Imidazopyridine inhibitors of tyrosine kinase. The present disclosure provides compounds and comp... 2022 Invention Inhibitors of ras oncoproteins Invention Inhibitors of ras oncoproteins. 111 1 group; R1is selected from the group consisting of: wherein ... 2021 Invention Inhibitors of yap/taz-tead oncoproteins, synthesis and use thereof. Disclosed herein are synthes... Invention Inhibitors of yap/taz-tead oncoproteins, synthesis and use thereof. Disclosed herein are synthesi... 2020 Invention Method for proteome-wide discovery of covalent ligands and compositions thereof. The present dis... Invention Method for proteome-wide discovery of covalent ligands and compositions thereof. The present disc... Invention Inhibitors of tyrosine kinase. The present disclosure provides compounds and compositions thereo... Invention Inhibitors of tyrosine kinase. The present disclosure provides compounds and compositions thereof... Invention Fgfr inhibitors for the treatment of cancer. The disclosure provides novel FGFR inhibitors based... Invention Fgfr inhibitors for the treatment of cancer. The disclosure provides novel FGFR inhibitors based ...